Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies.
Saved in:
| Title: | Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies. |
|---|---|
| Authors: | Lampe JW; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Alford JS; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Boriak-Sjodin PA; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Brach D; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Cosmopoulos K; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Duncan KW; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Eckley ST; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Foley MA; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Harvey DM; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Motwani V; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Munchhof MJ; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Raimondi A; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Riera TV; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Tang C; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Thomenius MJ; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Totman J; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States., Farrow NA; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States. |
| Source: | ACS medicinal chemistry letters [ACS Med Chem Lett] 2021 Aug 24; Vol. 12 (10), pp. 1539-1545. Date of Electronic Publication: 2021 Aug 24 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34671445 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lampe+JW%22">Lampe JW</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Alford+JS%22">Alford JS</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Boriak-Sjodin+PA%22">Boriak-Sjodin PA</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Brach+D%22">Brach D</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Cosmopoulos+K%22">Cosmopoulos K</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Duncan+KW%22">Duncan KW</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Eckley+ST%22">Eckley ST</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Foley+MA%22">Foley MA</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Harvey+DM%22">Harvey DM</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Motwani+V%22">Motwani V</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Munchhof+MJ%22">Munchhof MJ</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Raimondi+A%22">Raimondi A</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Riera+TV%22">Riera TV</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Tang+C%22">Tang C</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Thomenius+MJ%22">Thomenius MJ</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Totman+J%22">Totman J</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Farrow+NA%22">Farrow NA</searchLink>; Epizyme Inc., 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101521073%22">ACS medicinal chemistry letters</searchLink> [ACS Med Chem Lett] 2021 Aug 24; Vol. 12 (10), pp. 1539-1545. <i>Date of Electronic Publication: </i>2021 Aug 24 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101521073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1948-5875 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219485875%22">19485875 </searchLink><i>NLM ISO Abbreviation: </i>ACS Med Chem Lett <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34671445 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acsmedchemlett.1c00272 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1539 Titles: – TitleFull: Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lampe JW – PersonEntity: Name: NameFull: Alford JS – PersonEntity: Name: NameFull: Boriak-Sjodin PA – PersonEntity: Name: NameFull: Brach D – PersonEntity: Name: NameFull: Cosmopoulos K – PersonEntity: Name: NameFull: Duncan KW – PersonEntity: Name: NameFull: Eckley ST – PersonEntity: Name: NameFull: Foley MA – PersonEntity: Name: NameFull: Harvey DM – PersonEntity: Name: NameFull: Motwani V – PersonEntity: Name: NameFull: Munchhof MJ – PersonEntity: Name: NameFull: Raimondi A – PersonEntity: Name: NameFull: Riera TV – PersonEntity: Name: NameFull: Tang C – PersonEntity: Name: NameFull: Thomenius MJ – PersonEntity: Name: NameFull: Totman J – PersonEntity: Name: NameFull: Farrow NA IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 08 Text: 2021 Aug 24 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1948-5875 Numbering: – Type: volume Value: 12 – Type: issue Value: 10 Titles: – TitleFull: ACS medicinal chemistry letters Type: main |
| ResultId | 1 |